Skip to main content

Venrock — Portfolio, Page 3

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

156
Companies
$8.0B
Total invested
$54.9M
Avg. check
47
Industries
Health Care 10Biotechnology 9Software 8Therapeutics 5Information Technology 4Medical 4+41 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 49–72 of 156
SmithRx
January 2024

SmithRx is reinventing PBMs with modern technology, client alignment, and 100% transparency.

Health Care · San Francisco$60.0M Series C
Keros Therapeutics
January 2024

Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.

Biotechnology · Lexington$140.0M Post-IPO Equity
MBrace Therapeutics
November 2023

MBrace Therapeutics is a privately held biopharmaceutical business.

Biotechnology · San Diego$85.0M Series B
Tisento Therapeutics
July 2023

Tisento Therapeutics is a MA-based developer of novel medicines to treat diseases with significant unmet medical needs.

Health Care · Cambridge$81.0M Series A
Ocelot Bio
July 2023

Ocelot Bio brings new treatment options to patients with severe liver disease.

Biotechnology · San Diego$3.0M Debt Financing
SQLite Cloud
July 2023

Deploy your app on SQLite, everywhere. With high concurrency and built for scale.

Cloud Computing · San Francisco$4.3M Seed
Running Tide
July 2023

The global ocean health company harnessing the power of ocean for a climate positive future.

CleanTech · Portland$250K Grant
Aeglea BioTherapeutics
June 2023

Aeglea BioTherapeutics is a clinical-stage biotechnology company that develops enzyme therapies for rare metabolic diseases.

Biotechnology · Austin$210.0M Post-IPO Equity
Airspeed
May 2023

Airspeed is a team-building platform for modern companies to connect digitally.

Information Services · Vancouver$5.0M Seed
Epic Sciences
April 2023

Epic Sciences is a diagnostics company improving cancer management by providing real-time biopsy material to guide personalized medicine.

Biotechnology · La Jolla$24.0M Series G
Inscripta
January 2023

Inscripta is a life science technology company that develops digital genome engineering solutions.

Biotechnology · Pleasanton$4.4M Venture - Series Unknown
Mobile.dev
January 2023

mobile.dev is setting a new standard for mobile development, empowering all companies to deliver high-quality mobile applications.

Mobile Apps · San FranciscoSeed
Fygr
December 2022

Fygr is a cash management and forecasting solution service.

Finance · Paris$2.1M Venture - Series Unknown
Lusaris Therapeutics
November 2022

Lusaris Therapeutics develops small-molecule neuroplastogen therapeutics for neuropsychiatric and neurological disorders.

Biotechnology · Boston$60.0M Series A
Tricida
October 2022

Tricida operates in the healthcare industry focusing on pharmaceutical business.

Health Care · Menlo Park$125.0M Post-IPO Debt
Kyruus
September 2022

Kyruus provides health systems with search and scheduling solutions to connect patients with the right providers across all access points.

Business Information Systems · Boston$35.1M Venture - Series Unknown
Nightfall
August 2022

Nightfall is a cloud data protection platform that uses machine learning to identify and detect business-critical data.

Analytics · San Francisco$40.0M Series B
Arch Data
June 2022

Arch Data is an AI data analytical software that delivers personalized insights and analytics for organizations.

Analytics · Austin$8.2M Seed
The Public Health Company
May 2022

Developing the first global biosecurity platform to provide enterprises a SaaS-enabled service for the management of bio-risks.

Biotechnology · Palo Alto$35.0M Series A
Kelonia Therapeutics
April 2022

Kelonia Therapeutics develops genetic medicines focused on in vivo gene delivery and cell therapy for cancer and other diseases.

Biotechnology · Boston$50.0M Series A
Salsify
April 2022

Salsify helps brands by providing tools to track and analyze inventories, presentation, and sales of goods on digital shelves.

Analytics · Boston$200.0M Series F
Quiq
April 2022

Quiq is the only enterprise agentic AI platform that IT, CX, and eCommerce leaders can agree on.

Agentic AI · Bozeman$25.0M Series C
Decodable
February 2022

Decodable is a serverless data integration and engineering platform for streaming data.

Developer Platform · San Francisco$20.0M Series A
Socrates.AI, Inc.
February 2022

Socrates AI brings deep expertise in Artificial Intelligence.

Artificial Intelligence (AI) · San FranciscoSeries A

Where Venrock invests

Health Care10
Biotechnology9
Software8
Therapeutics5
Information Technology4
Medical4

About Venrock's portfolio

How many companies has Venrock invested in?▸

Venrock has invested in 156 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Venrock invest in?▸

Venrock's top investment sectors include Health Care, Biotechnology, Software, Therapeutics, Information Technology. The firm invests across 47 different industry categories.

What is Venrock's largest investment?▸

Among tracked funding rounds, Aeglea BioTherapeutics received $210.0M in a Post-IPO Equity round. Venrock's total known invested capital is $8.0B.

What is the average investment size for Venrock?▸

Venrock's average investment size is $54.9M across its portfolio of 156 companies.

What are Venrock's most recent investments?▸

Recent Venrock portfolio additions include SmithRx, Keros Therapeutics, MBrace Therapeutics, Tisento Therapeutics, Ocelot Bio. These companies were founded in 2020 or later.

Reach the founders behind these 156 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →